pramipexole - Compound Summary (CID 59868) Also known as: Mirapex, Dexpramipexole, Pramipexol, 104632-28-2, STK621530, Pramipexol [Spanish], Pramipexolum [Latin], Pramipexole 2HCl Monohydrate Molecular Formula: C 10H 17N 3S Molecular Weight: 211.32708 InChIKey: FASDKYOPVNHBLU-SSDOTTSWSA-N Pramipexole (INN, trade names Mirapex® and Sifrol®) is a medication indicated for treating Parkinson's disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist. From: DrugBank |
| | |
Identification Related Records Use and Manufacturing Pharmacology Literature Patents Biomolecular Interactions and Pathways Biological Test Results Classification Chemical and Physical Properties |